Literature DB >> 18195198

Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease.

Andrew Briggs1, Michael Spencer, Hong Wang, David Mannino, Don D Sin.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a debilitating and progressive disease. The severity of the condition has typically been characterized by a single physiological measurement: forced expiratory volume in 1 second, which has been shown to be prognostic for mortality.
METHODS: To develop a prognostic tool for COPD that is sensitive not only to mortality but also to other important drivers of health status and cost, data were obtained from a pooled analysis of 12 randomized controlled trials and 3 main outcomes were chosen: mortality, hospitalization, and number of exacerbations. Cox models were employed for the time-to-event data (death or hospitalization), and a negative binomial model was used for calculating the count data (exacerbations). From these models, 3 specific indexes were developed on a 100-point scale, and 1 composite index was obtained as a mean of the specific indexes. One-third of the data was reserved for validation purposes.
RESULTS: All indexes provided good discrimination among tertiles in the training and validation samples. The composite index had a performance very similar to that of the specific index in both the training and validation samples: the overall C statistic was estimated as 0.71 for both mortality and hospitalization. Each 10-point change in the composite index corresponds to an increase of 54% in the hazard ratio of death, 57% in the hazard ratio of hospitalization, and 21% in the incidence rate of exacerbations.
CONCLUSIONS: A composite index for COPD prognosis (the COPD Prognostic Index) has been validated in data not used in its development and is capable of predicting not only mortality, but also hospitalizations and exacerbations. All factors included in the index are straightforward to obtain, which should make the index suitable for use in primary as well as secondary care settings.

Entities:  

Mesh:

Year:  2008        PMID: 18195198     DOI: 10.1001/archinternmed.2007.37

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  21 in total

1.  Chronic obstructive pulmonary disease phenotypes: the future of COPD.

Authors:  MeiLan K Han; Alvar Agusti; Peter M Calverley; Bartolome R Celli; Gerard Criner; Jeffrey L Curtis; Leonardo M Fabbri; Jonathan G Goldin; Paul W Jones; William Macnee; Barry J Make; Klaus F Rabe; Stephen I Rennard; Frank C Sciurba; Edwin K Silverman; Jørgen Vestbo; George R Washko; Emiel F M Wouters; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

2.  Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial.

Authors:  Afisi S Ismaila; Nancy Risebrough; Melanie Schroeder; Dhvani Shah; Alan Martin; Emma C Goodall; Kerigo Ndirangu; Gerard Criner; Mark Dransfield; David Mg Halpin; MeiLan K Han; David A Lomas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-11-29

3.  Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score.

Authors:  Nitin Mehrotra; Amado X Freire; Douglas C Bauer; Tamara B Harris; Anne B Newman; Stephen B Kritchevsky; Bernd Meibohm
Journal:  Ann Epidemiol       Date:  2010-03       Impact factor: 3.797

4.  Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease.

Authors:  Toru Oga; Mitsuhiro Tsukino; Takashi Hajiro; Akihiko Ikeda; Koichi Nishimura
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-10-11

Review 5.  Multidimensional prognostic indices for use in COPD patient care. A systematic review.

Authors:  Wouter D van Dijk; Lisette van den Bemt; Saskia van den Haak-Rongen; Erik Bischoff; Chris van Weel; Johannes C C M in 't Veen; Tjard R J Schermer
Journal:  Respir Res       Date:  2011-11-14

6.  Adjusting for COPD severity in database research: developing and validating an algorithm.

Authors:  Lucas M A Goossens; Christine L Baker; Brigitta U Monz; Kelly H Zou; Maureen P M H Rutten-van Mölken
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-12-06

7.  A score to predict short-term risk of COPD exacerbations (SCOPEX).

Authors:  Barry J Make; Göran Eriksson; Peter M Calverley; Christine R Jenkins; Dirkje S Postma; Stefan Peterson; Ollie Östlund; Antonio Anzueto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-01-27

8.  Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.

Authors:  Frank Trudo; David M Kern; Jill R Davis; Ozgur Tunceli; Siting Zhou; Emma L Graham; Charlie Strange; Setareh A Williams
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-28

9.  Prediction of COPD-specific health-related quality of life in primary care COPD patients: a prospective cohort study.

Authors:  Lara Siebeling; Jammbe Z Musoro; Ronald B Geskus; Marco Zoller; Patrick Muggensturm; Anja Frei; Milo A Puhan; Gerben ter Riet
Journal:  NPJ Prim Care Respir Med       Date:  2014-08-28       Impact factor: 2.871

10.  Prediction of acute respiratory disease in current and former smokers with and without COPD.

Authors:  Russell P Bowler; Victor Kim; Elizabeth Regan; André A A Williams; Stephanie A Santorico; Barry J Make; David A Lynch; John E Hokanson; George R Washko; Peter Bercz; Xavier Soler; Nathaniel Marchetti; Gerard J Criner; Joe Ramsdell; MeiLan K Han; Dawn Demeo; Antonio Anzueto; Alejandro Comellas; James D Crapo; Mark Dransfield; J Michael Wells; Craig P Hersh; Neil MacIntyre; Fernando Martinez; Hrudaya P Nath; Dennis Niewoehner; Frank Sciurba; Amir Sharafkhaneh; Edwin K Silverman; Edwin J R van Beek; Carla Wilson; Christine Wendt; Robert A Wise
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.